Product NDC: | 24208-443 |
Proprietary Name: | Lotemax |
Non Proprietary Name: | loteprednol etabonate |
Active Ingredient(s): | 5 mg/g & nbsp; loteprednol etabonate |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24208-443 |
Labeler Name: | Bausch & Lomb Incorporated |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA200738 |
Marketing Category: | NDA |
Start Marketing Date: | 20110415 |
Package NDC: | 24208-443-35 |
Package Description: | 1 TUBE in 1 CARTON (24208-443-35) > 3.5 g in 1 TUBE |
NDC Code | 24208-443-35 |
Proprietary Name | Lotemax |
Package Description | 1 TUBE in 1 CARTON (24208-443-35) > 3.5 g in 1 TUBE |
Product NDC | 24208-443 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | loteprednol etabonate |
Dosage Form Name | OINTMENT |
Route Name | OPHTHALMIC |
Start Marketing Date | 20110415 |
Marketing Category Name | NDA |
Labeler Name | Bausch & Lomb Incorporated |
Substance Name | LOTEPREDNOL ETABONATE |
Strength Number | 5 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |